Latest News

UCB and Dermira report positive Phase III trial results of Cimzia to treat chronic plaque psoriasis

UCB and Dermira report positive Phase III trial results of Cimzia to treat chronic plaque psoriasis

M&As this week: Malin Corporation, Eli Lilly and Company

Irish life sciences company Malin Corporation has acquired 33% stake in Wren Therapeutics with the aim of developing rational therapeutic...

M&As this week: Malin Corporation, Eli Lilly and Company

Daiichi Sankyo begins Phase I/II trial of U3-1402 to treat breast cancer in Japan

Japanese-based pharmaceutical company Daiichi Sankyo has begun its Phase I/II trial of U3-1402 to treat patients with HER3-positive metastatic or unresectable breast cancer in...

Daiichi Sankyo begins Phase I/II trial of U3-1402 to treat breast cancer in Japan

Deals this week: Takeda Pharmaceutical, HUYA Bioscience International, Egalet

Japanese pharmaceutical company Takeda Pharmaceutical has signed a global agreement with US-based bio-pharmaceutical company Ovid Therapeutics for clinical development and commercialisation of...

Deals this week: Takeda Pharmaceutical, HUYA Bioscience International, Egalet

Protagonist Therapeutics initiates Phase IIb trial of PTG-100 to treat ulcerative colitis

Protagonist Therapeutics initiates Phase IIb trial of PTG-100 to treat ulcerative colitis

Interface Clinical Research suggests new model for primary care clinical trials in UK

UK-based clinical trials company Interface Clinical Research has suggested a new model to conduct primary care clinical trials following their launch at the Royal Society in...

Interface Clinical Research suggests new model for primary care clinical trials in UK

SWOG to conduct immunotherapy clinical trial to treat rare cancers

SWOG, a part of National Cancer Institute’s National Clinical Trials Network and the NCI Community Oncology Research Programme, has launched the DART immunotherapy trial of ipilimumab and...

SWOG to conduct immunotherapy clinical trial to treat rare cancers

Jazz Pharmaceuticals begins enrolment in Phase III trial of defitelio to treat VOD

Jazz Pharmaceuticals begins enrolment in Phase III trial of defitelio to treat VOD

Allergan and Gedeon Richter report positive results from Venus II trial of ulipristal acetate

Allergan and Gedeon Richter have reported positive results from Venus II, the second of two pivotal phase III clinical trials evaluating the efficacy and safety of ulipristal acetate in women...

Allergan and Gedeon Richter report positive results from Venus II trial of ulipristal acetate

New clinical trial to test drug combination to treat osteogenesis imperfecta

The University of Edinburgh will conduct a six-year trial of teriparatide and zoledronic acid combination to treat a condition called osteogenesis imperfecta (OI). ...

New clinical trial to test drug combination to treat osteogenesis imperfecta

Chi-Med initiates Phase II study of sulfatinib to treat second-line biliary tract cancer in China

Chi-Med initiates Phase II study of sulfatinib to treat second-line biliary tract cancer in China

BioLineRx begins Phase IIa trial of BL-8040 combined with KEYTRUDA to treat metastatic pancreatic cancer

Clinical-stage bio-pharmaceutical company BioLineRx has begun its second Phase 2a trial investigating BL-8040 in combination with KEYTRUDA (pembrolizumab), MSD's anti-PD-1 therapy, in...

BioLineRx begins Phase IIa trial of BL-8040 combined with KEYTRUDA to treat metastatic pancreatic cancer

Clinical study suggests efficacy of modafinil to improve memory in patients with depression

Clinical study suggests efficacy of modafinil to improve memory in patients with depression

Tocagen commences Phase 2/3 clinical trial for recurrent brain cancer in South Korea

Tocagen commences Phase 2/3 clinical trial for recurrent brain cancer in South Korea

Pluristem closes enrolment for Phase II trial of PLX-PAD cells to treat intermittent claudication

Israeli-based drug development company Pluristem Therapeutics has closed enrolment for its Phase II trial of placental expanded (PLX-PAD) cells to treat intermittent claudication (IC), a...

Pluristem closes enrolment for Phase II trial of PLX-PAD cells to treat intermittent claudication

Sunovion reports results from Phase II/III (SEP360-221) study of dasotraline to treat BED

US-based biopharmaceutical company Sunovion has reported results from its Phase II/III (SEP360-221) study of dasotraline to treat moderate-to-severe binge eating disorder...

Sunovion reports results from Phase II/III (SEP360-221) study of dasotraline to treat BED

Visterra begins Phase IIa trial of VIS410 to treat hospitalised patients with influenza A

US-based clinical-stage biopharmaceutical company Visterra has commenced its Phase IIa clinical trial of VIS410 to treat hospitalised patients with influenza...

Visterra begins Phase IIa trial of VIS410 to treat hospitalised patients with influenza A

Deals this week: Zebra Biologics, Mount Tam Biotechnologies, Adynxx

Zebra Biologics and AbbVie have signed an agreement to jointly discover agonist antibody therapeutics for inflammatory diseases using the former’s function-based antibody discovery...

Deals this week: Zebra Biologics, Mount Tam Biotechnologies, Adynxx

MorphoSys partner to initiate Phase II trial of bimagrumab to treat obese patients with type 2 diabetes

German biotechnology company MorphoSys' partner Novartis is set to begin its Phase II clinical trial of bimagrumab to treat obese patients with type 2...

MorphoSys partner to initiate Phase II trial of bimagrumab to treat obese patients with type 2 diabetes

M&As this week: Allergan, Roche Holdings, Pharmaron

Irish pharmaceutical company Allergan has entered an option agreement with the shareholders of US-based Lysosomal Therapeutics (LTI), giving the former the right to acquire the...

M&As this week: Allergan, Roche Holdings, Pharmaron

Sanaria reports positive results from Phase II trial of PfSPZ Vaccine for malaria

Sanaria reports positive results from Phase II trial of PfSPZ Vaccine for malaria